このアプリケーションの一部のコンテンツは現時点では利用できません。
このような状況が続く場合は、にお問い合わせくださいフィードバック & お問い合わせ
1. (WO2019045121) TREATMENT OF CNS CONDITIONS



免責事項 PATENTSCOPE 上で提供される画像ファイル (PDF) が正式版です。ここに表示される HTML データは、利用者支援のために提供されるものです。データ作成の際には印刷文書や画像に含まれる情報が精密かつ正確に表されるよう細心の注意が払われていますが、データの伝送や変換に係る処理上の理由、また機械翻訳が行われる場合は (任意) 機械翻訳に固有の限界により、表示データに誤りや欠落が含まれる可能性があります。また、「」の記号が末尾に付されるハイパーリンクのリンク先は、WIPO により管理されない外部のリソースです。WIPO は、上記の点に関して一切の責任を負いません。

INTERNATIONAL SEARCH REPORT (ISR)
Part 1:  1  2  3  4  5  6          Part 2:  A  B  C  D  E 
International application No. Applicant's or agent's file reference
PCT/JP2018/032949 092765
International filing date (day/month/year) (Earliest) Priority Date (day/month/year)
30 August 2018 31 August 2017
Applicant
TAKEDA PHARMACEUTICAL COMPANY LIMITED
FOR FURTHER ACTION: See Form PCT/ISA/220 as well as, where applicable, item 5 below.
This international search report has been prepared by this International Searching Authority and is transmitted to the applicant according to Article 18. A copy is being transmitted to the International Bureau.
It is also accompanied by a copy of each prior art document cited in this report.
1. Basis of the report
a. With regard to the language, the international search was carried out on the basis of:
the international application in the language in which it was filed.
a translation of the international application into                                          which is the language of a translation furnished for the purposes of international search (Rules 12.3(a) and 23.1(b)).
b.
This international search report has been established taking into account the rectification of an obvious mistake authorized by or notified to this Authority under Rule 91 (Rule 43.6bis(a)).
c.
With regard to any nucleotide and/or amino acid sequence disclosed in the international application, the international search was carried out on the basis of a sequence listing:
2. Certain claims were found unsearchable
3. Unity of invention is lacking
4. Title of the invention
The text is approved as submitted by the applicant.
The text has been established by this Authority to read as follows:
5. Abstract
The text is approved as submitted by the applicant.
The text has been established, according to Rule 38.2, by this Authority as it appears in Box No. IV. The applicant may, within one month from the date of mailing of this international search report, submit comments to this Authority.
6. Drawings
a.
The figure of the drawings to be published with the abstract is Figure No. ____________
as suggested by the applicant.
as selected by this Authority, because the applicant failed to suggest a figure.
as selected by this Authority, because this figure better characterizes the invention.
b.
none of the figures is to be published with the abstract.

A. CLASSIFICATION OF SUBJECT MATTER

     A61K 31/444 (2006.01)i; A61P 25/08 (2006.01)i
According to International Patent Classification (IPC) or to both national classification and IPC

B. FIELDS SEARCHED

Minimum documentation searched (classification system followed by classification symbols):
     A61K; A61P
Documentation searched other than minimum documentation to the extent that such documents are included in the fields searched:
Electronic data base consulted during the international search (name of data base and, where practicable, search terms used):
EPO-Internal, BIOSIS, EMBASE, WPI Data

C. DOCUMENTS CONSIDERED TO BE RELEVANT

Category* Citation of document, with indication, where appropriate, of the relevant passages Relevant to claim No.
(1)
X
US 9586930 B2 (TAKEDA PHARMACEUTICALS CO [JP]) 07 March 2017 (2017-03-07)
26
Y
column 6, line 33 - line 40
1-27
column 8, line 49 - line 50
column 45, line 22 - line 31
example 44
column 111; example Experimental 3
claims 1,9
(2)
X
US 8648079 B2 (TAKEDA PHARMACEUTICAL [JP]) 11 February 2014 (2014-02-11)
26
cited in the application
Y
column 6, line 24 - line 32
1-27
column 8, line 37 - line 38
column 44, line 17 - line 25; claims 1-3
(3)
A
VON DEIMLING MARKUS ET AL, "Epileptic Encephalopathies-Clinical Syndromes and Pathophysiological Concepts", 22 February 2017 (2017-02-22), Vol. 17, No. 2, page 1-10,
XP036195111
[retrieved on  2017-02-22]
1-27
page 1, right-hand column, line 3 - line 13
*
Special categories of cited documents:
"A"
document defining the general state of the art which is not considered to be of particular relevance
"E"
earlier application or patent but published on or after the international filing date
"L"
document which may throw doubts on priority claim(s) or which is cited to establish the publication date of another citation or other special reason (as specified)
"O"
document referring to an oral disclosure, use, exhibition or other means
"P"
document published prior to the international filing date but later than the priority date claimed
"T"
later document published after the international filing date or priority date and not in conflict with the application but cited to understand the principle or theory underlying the invention
"X"
document of particular relevance; the claimed invention cannot be considered novel or cannot be considered to involve an inventive step when the document is taken alone
"Y"
document of particular relevance; the claimed invention cannot be considered to involve an inventive step when the document is combined with one or more other such documents, such combination being obvious to a person skilled in the art
"&"
document member of the same patent family

D. INFORMATION ON PATENT FAMILY MEMBERS

Patent document cited in search report Publication date
(day/month/year)
Patent family member(s) Publication date
(day/month/year)
US 9586930 B2
07 March 2017
AR 088226 A1
AU 2012321815 A1
BR 112014007257 A2
CA 2851087 A1
CL 2014000806 A1
CN 103842356 A
CO 6940432 A2
CR 20140151 A
DO P2014000064 A
EA 201490747 A1
EC SP14013329 A
EP 2763979 A1
GE P201706608 B
JP 6117191 B2
JP 2014528904 A
KR 20140072902 A
MA 35623 B1
NZ 623185 A
PE 11202014 A1
SG 2014010417 A
TN 2014000122 A1
TW 201329068 A
UA 115133 C2
US 2013090341 A1
US 2014088118 A1
US 2014088146 A1
US 2014228373 A1
US 2015376205 A1
US 2016326136 A1
US 2017145031 A1
UY 34365 A
WO 2013054822 A1
ZA 201402424 B
21 May 2014
24 April 2014
28 March 2017
18 April 2013
05 September 2014
04 June 2014
09 May 2014
26 May 2014
15 July 2014
29 August 2014
31 May 2014
13 August 2014
25 January 2017
19 April 2017
30 October 2014
13 June 2014
01 November 2014
29 January 2016
15 September 2014
27 June 2014
01 July 2015
16 July 2013
25 September 2017
11 April 2013
27 March 2014
27 March 2014
14 August 2014
31 December 2015
10 November 2016
25 May 2017
31 May 2013
18 April 2013
29 July 2015
US 8648079 B2
11 February 2014
AR 088226 A1
AU 2012321815 A1
BR 112014007257 A2
CA 2851087 A1
CL 2014000806 A1
CN 103842356 A
CO 6940432 A2
CR 20140151 A
DO P2014000064 A
EA 201490747 A1
EC SP14013329 A
EP 2763979 A1
GE P201706608 B
JP 6117191 B2
JP 2014528904 A
KR 20140072902 A
MA 35623 B1
NZ 623185 A
PE 11202014 A1
SG 2014010417 A
TN 2014000122 A1
TW 201329068 A
UA 115133 C2
US 2013090341 A1
US 2014088118 A1
US 2014088146 A1
US 2014228373 A1
US 2015376205 A1
US 2016326136 A1
US 2017145031 A1
UY 34365 A
WO 2013054822 A1
ZA 201402424 B
21 May 2014
24 April 2014
28 March 2017
18 April 2013
05 September 2014
04 June 2014
09 May 2014
26 May 2014
15 July 2014
29 August 2014
31 May 2014
13 August 2014
25 January 2017
19 April 2017
30 October 2014
13 June 2014
01 November 2014
29 January 2016
15 September 2014
27 June 2014
01 July 2015
16 July 2013
25 September 2017
11 April 2013
27 March 2014
27 March 2014
14 August 2014
31 December 2015
10 November 2016
25 May 2017
31 May 2013
18 April 2013
29 July 2015
Name and mailing address of the ISA/:
European Patent Office
P.B. 5818, Patentlaan 2, 2280 HV Rijswijk,
Netherlands
Telephone No. (+31-70)340-2040
Facsimile No. (+31-70)340-3016
Date of the actual completion of the international search:
22 November 2018
Date of mailing of the international search report:
30 November 2018
Authorized officer:
Young, Astrid
Top    Part 1: 1 2 3 4 5 6         Part 2: A B C D E